Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.476
Peer-review started: September 14, 2018
First decision: October 3, 2018
Revised: October 15, 2018
Accepted: November 23, 2018
Article in press: November 24, 2018
Published online: December 15, 2018
Processing time: 91 Days and 9.7 Hours
Irreversible electroporation (IRE) is a medical technique that utilizes high voltage pulses to create permanent nanopores in the cell membrane, which in turn induces apoptosis of the targeted cells. Although there are benefits of IRE, many adverse events should be taken into consideration before its use. We aimed to assess the efficacy of IRE ablation in nude mouse models providing an experimental basis for the clinical application of IRE treatment.
Animal models of pancreatic cancer were successfully established and were successfully treated by IRE treatment. Tumor cell proliferation and apoptosis were detected by different methods, which proved that this treatment was effective.
The main objectives aimed to determine changes in the morphology and function of pancreatic cancer cells after IRE treatment providing an experimental basis for the clinical application of IRE treatment.
Animal models of pancreatic cancer were successfully treated by IRE treatment. Histological assessment of the affected tissue was performed by hematoxylin and eosin staining. Quantification of cell proliferation and apoptosis was performed by evaluating Ki67 and caspase-3 levels, respectively. Flow cytometry was used to assess cell apoptosis. Ultrasound imaging was carried out to evaluate IRE treatment results. Pathological correlation studies showed IRE is effective for the targeted ablation of pancreatic tumors in an orthotopic mouse model. Ultrasound imaging was repeatedly carried out to evaluate IRE treatment results.
This study systematically assessed the efficacy of IRE ablation and demonstrated that the main advantage of IRE is in the conservation of blood vessel and bowel wall integrity. Clinical data of patients after the application of IRE treatment is needed to prove that IRE treatment is effective in treating patients with pancreatic cancer.
IRE ablation is safe and effective for treatment of pancreatic cancer in a mouse model. The implication of this study for future clinical practice is that advanced pancreatic cancer patients can use IRE ablation as an effective treatment.
The future direction of research is the extensive safety application of IRE ablation in patients. The best method for future research is to study the practical application of IRE ablation in patients.